{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:41:30Z","timestamp":1790095290459,"version":"4.0.1"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,4,15]]},"DOI":"10.2169\/internalmedicine.2366-23","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T22:57:25Z","timestamp":1693522645000},"page":"1081-1085","source":"Crossref","is-referenced-by-count":7,"title":["Drug-induced Interstitial Nephritis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid"],"prefix":"10.2169","volume":"63","author":[{"given":"Daichi","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Osugi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Kusunoki","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Okabe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Nakamatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tsujii Y, Nishida T, Osugi N, et al. Classification and clinical features of adverse drug reactions in patients with ulcerative colitis treated with 5-aminosalicylate acid: a single-center, observational study. Scand J Gastroenterol 57: 190-196, 2022.","DOI":"10.1080\/00365521.2021.1998601"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 56: 489-526, 2021.","DOI":"10.1007\/s00535-021-01784-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Goldstein F, DiMarino AJ Jr. Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease. J Clin Gastroenterol 31: 60-62, 2000.","DOI":"10.1097\/00004836-200007000-00014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimodate Y, Takanashi K, Waga E, Fujita T, Katsuki S, Nomura M. Exacerbation of bloody diarrhea as a side effect of mesalamine treatment of active ulcerative colitis. Case Rep Gastroenterol 5: 159-165, 2011.","DOI":"10.1159\/000326931"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Matsumoto S, Mashima H. Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease. Sci Rep 10: 22176, 2020.","DOI":"10.1038\/s41598-020-79207-z"},{"key":"6","unstructured":"6. Timsit MA, Anglicheau D, Liot\u00e9 F, Marteau P, Dryll A. Mesalazine-induced lupus. Rev Rhum Engl Ed 64: 586-588, 1997."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kirkpatrick AW, Bookman AA, Habal F. Lupus-like syndrome caused by 5-aminosalicylic acid in patients with inflammatory bowel disease. Can J Gastroenterol 13: 159-162, 1999.","DOI":"10.1155\/1999\/361431"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mizuno S, Ono K, Mikami Y, et al. 5-aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis. Intest Res 18: 69-78, 2020.","DOI":"10.5217\/ir.2019.00084"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hiraoka S, Fujiwara A, Toyokawa T, et al. Multicenter survey on mesalamine intolerance in patients with ulcerative colitis. J Gastroenterol Hepatol 36: 137-143, 2021.","DOI":"10.1111\/jgh.15138"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Patel H, Barr A, Jeejeebhoy KN. Renal effects of long-term treatment with 5-aminosalicylic acid. Can J Gastroenterol 23: 170-176, 2009.","DOI":"10.1155\/2009\/501345"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zallot C, Billioud V, Frimat L, Faure P, Peyrin-Biroulet L; CREGG (Club de Reflexion des Cabinets et Groupes d'H\u00e9pato-Gastroent\u00e9rologie). 5-aminosalicylates and renal function monitoring in inflammatory bowel disease: a nationwide survey. J Crohns Colitis 7: 551-555, 2013.","DOI":"10.1016\/j.crohns.2012.08.013"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Moledina DG, Perazella MA. Drug-Induced Acute Interstitial Nephritis. Clin J Am Soc Nephrol 12: 2046-2049, 2017.","DOI":"10.2215\/CJN.07630717"},{"key":"13","unstructured":"13. Farrington K, Levison DA, Greenwood RN, Cattell WR, Baker LR. Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q J Med 70: 221-233, 1989."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Praga M, Gonzalez E. Acute interstitial nephritis. Kidney Int 77: 956-961, 2010.","DOI":"10.1038\/ki.2010.89"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gisbert JP, Luna M, Gonzalez-Lama Y, et al. Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study. Gastroenterol Hepatol 31: 477-484, 2008.","DOI":"10.1157\/13127088"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Moss JG, Parry CM, Holt RCL, McWilliam SJ. 5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review. Eur J Med Res 27: 61, 2022.","DOI":"10.1186\/s40001-022-00687-y"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Guillo L, D'Amico F, Achit H, et al. Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: what the gastroenterologist should know. Dig Liver Dis 53: 691-696, 2021.","DOI":"10.1016\/j.dld.2021.01.015"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Saito D, Hayashida M, Sato T, et al. Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy. Intest Res 16: 273-281, 2018.","DOI":"10.5217\/ir.2018.16.2.273"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/8\/63_2366-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T03:30:32Z","timestamp":1713583832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/8\/63_2366-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2366-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"article-number":"2366-23"}}